Ontology highlight
ABSTRACT:
SUBMITTER: Minarro-Lleonar M
PROVIDER: S-EPMC10184122 | biostudies-literature | 2023 May
REPOSITORIES: biostudies-literature

Miñarro-Lleonar Marina M Bertran-Mostazo Andrea A Duro Jorge J Barril Xavier X Juárez-Jiménez Jordi J
Journal of medicinal chemistry 20230421 9
Targeted protein degradation is a promising therapeutic strategy, spearheaded by the anti-myeloma drugs lenalidomide and pomalidomide. These drugs stabilize very efficiently the complex between the E3 ligase Cereblon (CRBN) and several non-native client proteins (neo-substrates), including the transcription factors Ikaros and Aiolos and the enzyme Caseine Kinase 1α (CK1α,), resulting in their degradation. Although the structures for these complexes have been determined, there are no evident inte ...[more]